东北地区儿童肺炎支原体呼吸道感染中西医结合防治方案

Prevention and treatment scheme of integrated traditional Chinese and western medicine for respiratory tract infection of Mycoplasma pneumoniae in children in Northeast China

2023年秋冬季东北地区儿童肺炎支原体呼吸道感染病例数量明显增加。为进一步规范其临床防治,发挥中西医结合治疗优势,国家中医药传承创新中心重点病种小儿肺炎建设项目组联合东北地区中西医儿科专家,参照国家卫生健康委《儿童肺炎支原体肺炎诊疗指南(2023年版)》,结合东北地区寒地儿童发病的临床特点,从肺炎支原体呼吸道感染分类、中西医发病机制、临床表现、影像学及支气管镜表现、实验室检查、重要并发症预警以及感染期、肺炎期、恢复期的中西医治疗方式等达成中西医共识,以期切实解决肺炎支原体呼吸道感染的临床问题,并提高儿科医师对肺炎支原体呼吸道感染的综合诊治能力,进而推动肺炎支原体呼吸道感染中西医结合研究的发展。

In the autumn and winter of 2023,the number of children with Mycoplasma pneumoniae respiratory tract infections in Northeast China has increased significantly.In order to further standardize the clinical prevention and treatment and give full play to the advantages of integrated traditional Chinese and western medicine treatment,the construction project team of pediatric pneumonia(a key disease)of the National Center for Inheritance and Innovation of Traditional Chinese Medicine,and the pediatric experts of traditional Chinese and western medicine in Northeast China,by referring to the National Health Commission's Guidelines for the Diagnosis and Treatment of Mycoplasma Pneumoniae Pneumonia in Children(2023 Edition)and on the basis of the clinical characteristics of children in the cold regions of Northeast China,have reached a consensus on the classification of Mycoplasma pneumoniae respiratory tract infection,the pathogenesis of traditional Chinese and western medicine,clinical manifestations,imaging and bronchoscopic manifestations,laboratory examination,early warning of important complications,and the treatment of traditional Chinese and western medicine in the infection period,pneumonia period and recovery period.The aim is to effectively solve the clinical problems of Mycoplasma pneumoniae respiratory tract infection and improve the comprehensive abilities of pediatricians in the diagnosis and treatment of Mycoplasma pneumoniae respiratory tract infection,and then promote the development of integrated traditional Chinese and western medicine research in Mycoplasma pneumoniae respiratory tract infection.